Home > Analyse
Actualite financiere : Actualite bourse

AstraZeneca: gets positive opinion from EU agency

(CercleFinance.com) - AstraZeneca and Merck said the European Medicines Agency (EMA) panel has recommended a marketing authorisation of Lynparza tablets for use as a maintenance therapy for patients with ovarian cancer.

The CHMP recommendation is based on two randomised trials which showed that Lynparza reduced the risk of disease progression or death for platinum-sensitive relapsed patients compared to placebo, the companies said.

Copyright (c) 2018 CercleFinance.com. All rights reserved.